Piperacillin-tazobactam and Clarithromycin Co-administration
Clarithromycin can be co-administered with piperacillin-tazobactam. [1] The interaction between clarithromycin and piperacillin-tazobactam is classified as a minor interaction. [1] No special precautions are described beyond monitoring the effectiveness of antibiotic therapy. [1]
Interaction Type
A potential in vitro antagonism between macrolides and penicillins has been reported. [1] When these agents are given together, neither has predictable therapeutic efficacy based on the described in vitro data. [1] This interaction primarily affects expected antibiotic effectiveness rather than causing a direct pharmacokinetic interaction. [1]
Practical Clinical Monitoring
Antibiotic clinical response should be monitored when both agents are used together. [1] Culture results and clinical trajectory should guide modification or discontinuation of antibiotic therapy. [1]
Evidence Supporting This Recommendation
In vitro data show that clarithromycin (a macrolide) can demonstrate antagonism when combined with certain beta-lactams in some microbial strain testing. [2] The clinical interaction is therefore framed around possible effectiveness issues rather than a contraindication. [1]
Avoidance Considerations
Avoid assuming synergistic bactericidal activity from the combination because in vitro antagonism has been observed for some pathogen–drug pairings. [1] Antibiotic selection should align with the suspected pathogens and local susceptibility patterns. [1]